LaFrence Andrew D.C. 4
4 · Vyant Bio, Inc. · Filed Nov 24, 2021
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
LaFrence Andrew D.C.
Chief Financial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2021-11-23$2.00/sh+5,000$9,998→ 34,336 total
Holdings
- 29,866(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.